For decades, GE Healthcare's HyClone™ premium bovine serum products have exceeded industry standards for quality, purity, and regulatory compliance. With pioneering filtration techniques, contaminants are reduced without impact on cell performance. The collection and processing procedures ensure the premium bovine serum offers reproducible and dependable results.
HyClone™ serum processes are traceability certified by the International Serum Industry Association (ISIA) and, in addition, GE Healthcare has chosen to be an early adopter of Scientific Traceability by Oritain to prove the country of origin of their premium bovine serum products from the United States, Australia and New Zealand. Premium bovine serum samples from different regions have been analysed and Oritain has created a database of the unique 'Origin' Fingerprint' that is exclusive to each country of origin.
The independent nature of this traceability system means GE Healthcare are raising the standard, by going one step further to assure the origin of premium bovine serum.
The Life Sciences business of GE Healthcare provides a wide range of bioprocessing products and services that enable the development and manufacture of high-quality biotherapeutics and vaccines. Using our knowledge and expertise, we support our customers in increasing speed to market, while avoiding unnecessary costs and improving quality and performance in drug manufacturing. As a provider of high-quality products, customised technical and commercial services, as well as design and construction of complete biomanufacturing solutions, we support the biopharmaceutical industry in making health visions a reality.
"By partnering with Oritain, we are committing to supply our customers with products of exceptional quality and integrity" - GE Healthcare
Oritain verifies the origin of GE Healthcare premium bovine serum from the United States, Australia and New Zealand.
Find out more about GE Healthcare